Background & Purpose

Riksrevisionen has audited how effectively the state oversees medical devices like syringes, wheelchairs, and pregnancy tests. The audit highlighted a need to review which agency handles in-house manufactured medical products and how companies pay annual fees.

The Decision

The Swedish parliament took note of the government's report and closed the matter without making any new decisions or changing laws.

Does this affect you?

  • Medical technology companies: May face future changes regarding the annual fees they pay to Läkemedelsverket.
  • Healthcare providers: Will be affected indirectly if the state supervision of medical devices is reorganized between authorities.

In Practice

  • No immediate law changes or new rules take effect as a result of this parliamentary action.
  • The government may look into moving oversight of in-house manufactured medical products from one agency to another.
  • The fee model that medical technology companies pay to state authorities could be reviewed in the future.